Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies.
Autor: | Barone, Linda R.1, Boyer, Scott2, Damewood, Jr, James R.3, Fikes, James4, Ciaccio, Paul J.4 paul.ciaccio@astrazeneca.com |
---|---|
Zdroj: | Journal of Toxicology. 2012, p1-7. 7p. 2 Charts, 6 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |